The Journal of Organic Chemistry
Note
6-(Benzyloxy)-1,3,5-triazine-2,4(1H,3H)-dione (MonoBOT).
To a biphasic solution of sodium acetate (2.051 g, 25.0 mmol) and
N-methylmorpholine (110 μL, 1.00 mmol) in THF (10.0 mL) and
H2O (10.0 mL) was added 2-(benzyloxy)-4,6-dichloro-1,3,5-triazine
(1.280 g, 5.00 mmol) at 0 °C. After it stirred for 1 h, the mixture was
allowed to warm to rt. After it stirred for an additional 19 h, 1 M
aqueous HCl (1.0 mL) was added to the mixture. After careful
evaporation of THF, a precipitate was corrected and recrystallized
from EtOH to afford MonoBOT (923.4 mg, 84%) as colorless crystals.
Calcd for C17H28N3O3 322.2131. Found: 322.2145. IR (KBr): 2924,
2852, 1674, 1610, 1558, 1423, 1358, 1331 cm−1.
2,4-Dichloro-6-(3-phenylpropoxy)-1,3,5-triazine. To a solu-
tion of cyanuric chloride (1.00 g, 5.42 mmol) and ethyldiisopropyl-
amine (1.04 mL, 5.97 mmol) in CH2Cl2 was added 1 (739 μL, 5.42
mmol) at −20 °C. The mixture was stirred at −20 °C for 3 h, at 0 °C
for 7 h, and at rt for 1 h. Ethyldiisopropylamine (378 μL, 2.17 mmol)
was added at rt. After it stirred for an additional 6 h, the mixture was
diluted with CHCl3, washed with 1 M aqueous HCl (15 × 2 mL), and
brine. The organic layer was dried over MgSO4, filtered, and
concentrated under reduced pressure. The residue was purified by
column chromatography (hexane−EtOAc, 20:1) followed by
recrystallization from hexane to afford title compound (1.07 g, 70%)
as colorless crystals. Mp 53.6−54.8 °C; 1H NMR (600 MHz, CDCl3):
δ 7.32−7.27 (m, 2H), 7.24−7.17 (m, 3H), 4.49 (t, J = 6.3 Hz, 2H),
2.80 (t, J = 7.6 Hz, 2H), 2.19−2.11 (m, 2H). 13C NMR (150 MHz,
CDCl3): δ 172.7, 171.2, 140.6, 128.7, 128.5, 126.4, 69.8, 31.8, 30.0.
Anal. Calcd for C12H11Cl2N3O: C, 50.72; H, 3.90; N, 14.79. Found: C,
50.81; H, 4.00; N, 14.78. HRMS (DART-TOF) m/z: [M + H]+ Calcd
for C12H12Cl2N3O 284.0357. Found: 284.0368. IR (KBr): 3030, 1541,
1506, 1308, 1255, 1038 cm−1.
6-(3-Phenylpropoxy)-1,3,5-triazine-2,4(1H,3H)-dione (8). To
a solution of sodium acetate (430.7 mg, 5.25 mmol) and N-
methylmorpholine (38.5 μL, 0.35 mmol) in MeOH (17.5 mL) was
added 2,4-dichloro-6-(3-phenylpropoxy)-1,3,5-triazine (497.2 mg, 1.75
mmol) at 0 °C. The mixture was stirred at 0 °C for 2 h, at rt for 13 h,
and at 40 °C for 25 h. The mixture was concentrated under reduced
pressure, and CHCl3 was added to the residue. The mixture was
washed with sat. aqueous NH4Cl (20 mL), brine (20 mL), 1 M
aqueous HCl (10 mL) and concentrated under reduced pressure. The
residue was purified by column chromatography (CHCl3−MeOH,
19:1) followed by recrystallization from hexane−THF to afford 8
(271.4 mg, 63%) as colorless crystals. Mp 200 °C (decomp.); 1H
NMR (600 MHz, DMSO-d6): δ 12.16 (br s, 1H), 11.01 (br s, 1H),
7.32−7.27 (m, 2H), 7.25−7.16 (m, 2H), 4.27 (t, J = 6.6 Hz, 2H), 2.68
(t, J = 7.7 Hz, 2H), 2.02−1.94 (m, 2H). 13C NMR (150 MHz, DMSO-
d6): δ 161.4, 140.9, 128.4, 128.3, 125.9, 67.6, 31.0, 29.4. Anal. Calcd for
C12H13N3O3: C, 58.29; H, 5.30; N, 17.00. Found: C, 58.07; H, 5.25;
N, 16.93. HRMS (DART-TOF) m/z: [M + H]+ Calcd for
C12H14N3O3 248.1035. Found: 248.1033. IR (KBr): 3084, 2817,
1751, 1685, 1577, 1417, 1317 cm−1.
1
Mp 200 °C (decomp); H NMR (600 MHz, DMSO-d6): δ 12.24 (br
s, 1H), 11.07 (br s, 1H), 7.48−7.34 (m, 5H), 5.35 (s, 2H). 13C NMR
(100 MHz, DMSO-d6): δ 162.3, 153.9 (br s), 135.1, 128.49, 128.45,
128.42, 69.2. Anal. Calcd for C10H9N3O3: C, 54.79; H, 4.14; N, 19.17.
Found: C, 54.71; H, 4.12; N, 19.10. HRMS (DART-TOF) m/z: [M +
H]+ Calcd for C10H10N3O3 220.0722. Found: 220.0708. IR (KBr):
3076, 1751, 1736, 1684, 1577, 1313 cm−1.
1-Benzyl-4,6-bis(benzyloxy)-1,3,5-triazin-2(1H)-one (5). To a
mixture of DiBOT (154.7 mg, 0.500 mmol), cesium carbonate (177.2
mg, 0.544 mmol) and DMSO (1.0 mL) was added benzyl bromide
(62.4 μL, 0.525 mmol) at rt. After it stirred for 30 min, the mixture
was diluted with Et2O (4 mL) and washed with H2O (10 mL) and
brine (4 mL). The organic layer was dried over Na2SO4, filtered, and
concentrated under reduced pressure. The residue was purified by
column chromatography (CH2Cl2−EtOAc, 19:1) to afford 5 (130.8
1
mg, 65%) as a clear colorless oil. H NMR (400 MHz, CDCl3): δ
7.49−7.43 (m, 2H), 7.42−7.21 (m, 13H), 5.43 (s, 2H), 5.42 (s, 2H),
5.11 (s, 2H). 13C NMR (150 MHz, CDCl3): δ 168.9, 163.1, 156.9,
135.5, 135.3, 133.7, 129.3, 128.91, 128.87, 128.85, 128.77, 128.7,
128.6, 128.2, 72.0, 70.5, 45.7. Anal. Calcd for C24H21N3O3: C, 72.16;
H, 5.30; N, 10.52. Found: C, 72.54; H, 5.50; N, 10.44. HRMS (DART-
TOF) m/z: [M + H]+ Calcd for C24H22N3O3 400.1661. Found:
400.1685. IR (CHCl3): 1705, 1603, 1533, 1423, 1348, 1176 cm−1.
2,4,6-Trimethoxy-1,3,5-triazine (6).1,11 To a suspension of
NaHCO3 (205.8 mg, 2.45 mmol) in MeOH (2.80 mL) was added
cyanuric chloride (129.1 mg, 0.700 mmol) at rt. After it stirred for 2 h,
the mixture was warmed to 50 °C. After it stirred an additional 22 h,
the mixture was cooled to rt and concentrated under reduced pressure.
The residue was purified by column chromatography (hexane−EtOAc,
1:1) to afford 6 (110.1 mg, 92%) as colorless crystals. Mp 143.6−144.6
°C.
2-Chloro-4,6-bis(cyclohexylmethoxy)-1,3,5-triazine. A solu-
tion of cyanuric chloride (2.634 g, 15.0 mmol), cyclohexylmethanol
(4.59 mL, 37.5 mmol) and 1,10-phenanthroline (8.109 g, 45.0 mmol)
in xylene (50.0 mL) was heated to reflux for 20 h. After it cooled to rt,
the mixture was filtered through a Celite pad and concentrated under
reduced pressure. The residue was purified by column chromatog-
raphy (hexane−EtOAc, 30:1) followed by recrystallization from
hexane to afford title compound (4.392 g, 86%) as colorless crystals.
2-(Benzyloxy)-4-chloro-6-methoxy-1,3,5-triazine. A solution
of 2-(benzyloxy)-4,6-dichloro-1,3,5-triazine (200.0 mg, 0.781 mmol)
and 1,10-phenanthroline (154.8 mg, 0.859 mmol) in MeOH (1.56
mL) was stirred at 50 °C for 7.5 h. After it cooled to rt, the solvent was
evaporated under reduced pressure. The residue was purified by
column chromatography (hexane−EtOAc, 4:1) to afford title
compound (161.7 mg, 82%) as colorless crystals. Mp 64.9−66.2 °C;
1H NMR (400 MHz, CDCl3): δ 7.50−7.42 (m, 2H), 7.42−7.31 (m,
3H), 5.48 (s, 2H), 4.06 (s, 3H). 13C NMR (100 MHz, CDCl3): δ
172.9, 172.7, 172.1, 134.7, 128.84, 128.76, 128.6, 70.8, 56.2. Anal.
Calcd for C11H10ClN3O2: C, 52.50; H, 4.01; N, 16.70. Found: C,
52.63; H, 3.80; N, 16.75. HRMS (DART-TOF) m/z: [M + H]+ Calcd
for C11H11ClN3O2 252.0534. Found: 252.0515. IR (KBr): 1570, 1541,
1429, 1346, 1236, 1122 cm−1.
1
Mp 75.8−76.2 °C; H NMR (600 MHz, CDCl3): δ 4.22 (d, J = 6.2
Hz, 4H), 1.89−1.63 (m, 12H), 1.34−1.13 (m, 6H), 1.12−0.99 (m,
4H). 13C NMR (150 MHz, CDCl3): δ 172.6, 172.4, 74.5, 37.2, 29.8,
29.6, 26.4, 25.7. Anal. Calcd for C17H26ClN3O2: C, 60.08; H, 7.71; N,
12.36. Found: C, 60.35; H, 7.49; N, 12.28. HRMS (DART-TOF) m/z:
[M + H]+ Calcd for C17H27ClN3O2 340.1792. Found: 340.1820. IR
(KBr): 2927, 2854, 1576, 1522, 1508, 1342, 1072, 1007 cm−1.
4,6-Bis(cyclohexylmethoxy)-1,3,5-triazin-2(1H)-one (7). To a
solution of acetic acid (46 μL, 0.80 mmol) and N-methylmorpholine
(176 μL, 1.60 mmol) in MeOH (2.0 mL) was added 2-chloro-4,6-
bis(cyclohexylmethoxy)-1,3,5-triazine (135.9 mg, 0.400 mmol) at 0
°C. After it stirred for 1.5 h, the mixture was allowed to warm to rt.
After it stirred for an additional 1.5 h, 6 M aqueous HCl (0.13 mL)
was added to the mixture and concentrated under reduced pressure.
The residue was purified by column chromatography (CH2Cl2−
MeOH, 30:1) to afford 7 (121.3 mg, 94%) as a white solid. Mp 200.2−
202.4 °C; 1H NMR (600 MHz, CDCl3): δ 12.16 (br s, 1H), 4.23 (d, J
= 6.3 Hz, 4H), 1.90−1.63 (m, 12H), 1.32−1.12 (m, 6H), 1.06−0.93
(m, 4H). 13C NMR (150 MHz, CDCl3): δ 160.1, 74.7, 36.9, 29.6, 26.4,
25.6. Anal. Calcd for C17H27N3O3: C, 63.53; H, 8.47; N, 13.07. Found:
C, 63.45; H, 8.41; N, 13.13. HRMS (DART-TOF) m/z: [M + H]+
2-(Benzyloxy)-4,6-dimethoxy-1,3,5-triazine (10). A solution of
2-(benzyloxy)-4-chloro-6-methoxy-1,3,5-triazine (200.0 mg, 0.795
mmol) and 1,10-phenanthroline (286.4 mg, 1.59 mmol) in MeOH
(1.6 mL) was heated to reflux. After it stirred for 77 h, MeOH (1.6
mL) was added and the mixture was stirred at reflux for an additional
83 h. After the solution cooled to rt, the solvent was evaporated under
reduced pressure. The residue was purified by column chromatog-
raphy (CHCl3−MeOH, 100:1) to afford 10 (113.3 mg, 58%) as
1
colorless crystals. Mp 65.0−66.6 °C; H NMR (400 MHz, CDCl3): δ
7.49−7.42 (m, 2H), 7.41−7.29 (m, 3H), 5.45 (s, 2H), 4.03 (s, 6H).
13C NMR (100 MHz, CDCl3): δ 173.7, 173.1, 135.5, 128.7, 128.6,
128.5, 70.0, 55.5. Anal. Calcd for C12H13N3O3: C, 58.29; H, 5.30; N,
16.99. Found: C, 58.15; H, 5.36; N, 16.88. HRMS (DART-TOF) m/z:
[M + H]+ Calcd for C12H14N3O3 248.1035. Found: 248.1023. IR
(KBr): 2951, 1558, 1348, 1130 cm−1.
E
J. Org. Chem. XXXX, XXX, XXX−XXX